Готові списки джерел за темами / Hepatitis B and Hepatitis C

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Hepatitis B and Hepatitis C"

Автор: Grafiati
Опубліковано: 3 червня 2025
Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Hepatitis B and Hepatitis C".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Hepatitis B and Hepatitis C"

1

Jain, Ravi, and Ashok Yadav. "Hepatitis B Versus Hepatitis C in Blood Donors." Annals of Applied Bio-Sciences 4, no. 1 (2017): A8—A13. http://dx.doi.org/10.21276/aabs.2017.1306.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Повний текст джерела
Анотація:
Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/18.4766.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Повний текст джерела
Анотація:
INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Huma Qureshi, Saeed Akhter, Hassan Mahmood, et al. "Overview of Hepatitis C Elimination Efforts in Pakistan and the Launch of Prime Minister’s Programme for the Elimination of Hepatitis C." Journal of the Pakistan Medical Association 74, no. 12 (2024): 2188–90. http://dx.doi.org/10.47391/jpma.24-97.

Повний текст джерела
Анотація:
Hepatitis B and C are serious viral infections that cancause liver damage and death. According to the WorldHealth Organization (WHO), there are currently 2.8 millionpeople living with hepatitis B in Pakistan, and 9.8 millionpeople living with hepatitis C.1 These numbers representa significant burden of disease for the country. Thecurrent prevalence of hepatitis B in Pakistan is 1.1%,which corresponds to one-quarter of the burden of thedisease in the Eastern Mediterranean region.1 Theprevalence of hepatitis C is 7.5%, which is the highest inthe world. Almost 37,000 people die each year in Pakis
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Shahbaz, Tazeem, Ghulam Farid, Raja Sajjad Asghar, and Abdul Rashid. "HEPATITIS B AND C." Professional Medical Journal 22, no. 11 (2015): 1383–89. http://dx.doi.org/10.29309/tpmj/2015.22.11.859.

Повний текст джерела
Анотація:
Background and Aims: The working conditions of Health care workers (HCW’S)expose them for a constant threat of contracting and spreading hepatitis B (HBV) and C virus(HCV) not only to their patients but family members as well. The aim of this study was to assessthe knowledge and attitude toward hepatitis B and C infection among the health-care workersand correlate the level of awareness to their behavior towards prevention of the disease. StudySettings: The study was conducted in Rashid Latif medical college and its two affiliated hospitals(Arif memorial teaching hospital and Hameed Latif Hosp
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Tagar, Muhammad Paryal, Mujeeb Rehman Abbasi, Mohammad Rafique Pathan, and Hafeezullah Shaikh. "HEPATITIS B & C;." Professional Medical Journal 24, no. 02 (2017): 278–81. http://dx.doi.org/10.29309/tpmj/2017.24.02.508.

Повний текст джерела
Анотація:
Objectives: To determine the frequency of hepatitis b & c viral infection insurgical patients. Study Design: Descriptive case series. Place and Duration of Study: Thisstudy was conducted at surgical department of multiple hospitals and compares the results,JPMC Karachi, Civil Hospital Naushahro Feroze and Jamshoro, Pakistan from August 2014 toDecember 2015. Methodology: All 2645 patients were admitted for emergency and electivesurgery. All patients taken detail history regarding demographic parameter and risk factorslike previous surgery, blood transfusion, barbar, Road Traffic accident, h
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Dar, Ghayas Ud Din, Muhammad Imran Qader, Shafique Ahmed Chudhary, Dania Aijaz, Shahid Imtiaz, and Tahir Naveed. "Frequency of HBsAg and Anti-HCV among Hemodialysis Patients in Three General Hospitals of Azad Kashmir." International Journal of Frontier Sciences 4, no. 1 (2020): 52–54. https://doi.org/10.5281/zenodo.3613537.

Повний текст джерела
Анотація:
<strong>ABSTRACT</strong> <strong>Background</strong>: The impact of dialysis modality on the rates and types of infectious complications has not been well studied. The aim of the present investigation was to evaluate the rates of hepatitis C virus and hepatitis B virus infections in hemodialysis patients in three general hospitals of Azad Kashmir. In dialysis patient, if left unaddressed these may lead to very fatal consequences at the individual and national level. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections represent significant public health issues globally. These infect
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C;." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/2018.25.08.88.

Повний текст джерела
Анотація:
Objectives: To determine the frequency of HBV and HCV among blood donorscoming voluntarily at the blood bank of Ibne- Siena hospital and research centre, Multan,Pakistan, to ascertain the disease burden in the community for their future prevention andcontrol. Study Design: It was a descriptive, cross- sectional study on blood units donated byhealthy individuals coming voluntarily for blood donation, and willing to get their blood testedfor HBV, HCV. Setting: Community medicine department of Multan medical and dental collegeMultan, and blood bank of affiliated tertiary hospital, Ibn-e- Siena ho
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Geller, Stephen A. "Hepatitis B and hepatitis C." Clinics in Liver Disease 6, no. 2 (2002): 317–34. http://dx.doi.org/10.1016/s1089-3261(02)00008-9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Hepatitis B and Hepatitis C"

1

Valente, Vanderleia Barbaro. "Estudo da distribuição dos marcadores sorológicos das hepatites B e C entre doadores de sangue do Hemocentro de Ribeirão Preto, SP." Universidade de São Paulo, 2002. http://www.teses.usp.br/teses/disponiveis/17/17139/tde-29052003-193717/.

Повний текст джерела
Анотація:
Este estudo, que envolveu todos os doadores de sangue (25.891) que compareceram pela primeira vez ao Hemocentro de Ribeirão Preto, de junho de 1996 a junho de 2001, teve os seguintes objetivos: 1) Estudar a positividade de marcadores sorológicos das hepatites B e C em testes da triagem dos doadores. 2) Analisar o fluxo dos doadores positivos para os marcadores das hepatites B e C ao Ambulatório de Hepatites (AH) do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. 3) Estimar a prevalência de infecção atual ou pregressa pelos vírus das hepatites B e C entre os doadores, através
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Silva, Filho Hermes Pedreira da. "Estudo Molecular dos Vírus B e C das Hepatites nas Regiões Norte e Nordeste do Brasil." reponame:Repositório Institucional da FIOCRUZ, 2010. https://www.arca.fiocruz.br/handle/icict/4219.

Повний текст джерела
Анотація:
Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2012-07-19T21:21:54Z No. of bitstreams: 1 Hermes Pedreira EStudo molecular dos vírus B e C...2010.pdf: 5589974 bytes, checksum: b86706272dbb22d0d349edae7d641ce1 (MD5)<br>Made available in DSpace on 2012-07-19T21:21:54Z (GMT). No. of bitstreams: 1 Hermes Pedreira EStudo molecular dos vírus B e C...2010.pdf: 5589974 bytes, checksum: b86706272dbb22d0d349edae7d641ce1 (MD5) Previous issue date: 2010<br>Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil<br>Infecções pelos vírus B e C das hepatit
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Silva, Edvaldo Ferreira da. "Prevalência de marcadores sorológicos das hepatites A e B em pacientes com hepatite C crônica atendidos no ambulatório de hepatites do serviço de Gastroenterologia Clínica do Hospital das Clínicas da Faculdade de Medicina da Universidade." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5168/tde-04022015-153903/.

Повний текст джерела
Анотація:
Introdução: Pacientes com infecção crônica pelo VHC e superinfecção pelo vírus da hepatite A (VHA) ou o vírus da hepatite B (VHB), têm maior morbi-mortalidade quando comparados com pacientes que apresentam infecção aguda somente pelo VHA ou VHB. A mortalidade associada à hepatite A aguda pode estar particularmente elevada em pacientes com pré-existência de hepatite crônica causada pelo VHC. Por esta razão, a imunização ativa com vacinas contra o VHA e o VHB vem a ser obrigatória nesta população, e consequentemente esta sorologia deve ser determinada. Objetivos: O objetivo deste trabalho foi a
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Ciaccia, Maria Celia Cunha. "Aspectos epidemiológicos, sorológicos e moleculares das hepatites A, B e C em crianças e adolescentes matriculados em creches e escolas do ensino infantil e fundamental da rede municipal na cidade de Santos." Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-14012013-120337/.

Повний текст джерела
Анотація:
As hepatites virais continuam sendo uma preocupação em nível de saúde pública no Brasil e no Mundo, tanto pelo número de indivíduos atingidos, como pela possibilidade de complicação das formas agudas e crônicas. Segundo a Organização Mundial de Saúde (OMS), 170 milhões de pessoas são portadoras crônicas de hepatite C e 350 milhões portadoras crônicas de hepatite B. No Brasil, a estimativa de portadores de hepatite B crônica é de aproximadamente 600 mil pessoas e de hepatite C crônica, 1,5 milhão. Quanto à hepatite aguda A foram confirmados no país, em 2010, 5943 casos. O objetivo deste estudo
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Oliveira, Célia Figueiredo de. "Detecção de marcadores sorológicos para hepatite A, B e C associados ao perfil epidemiológico em uma população de estudantes universitários no interior de São Paulo-SP." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311371.

Повний текст джерела
Анотація:
Orientadores: Neiva Sellan Lopes Gonçales, Fernando Lopes Gonçales Júnior<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas<br>Made available in DSpace on 2018-08-16T12:25:04Z (GMT). No. of bitstreams: 1 Oliveira_CeliaFigueiredode_M.pdf: 786699 bytes, checksum: 0a829d305315144f635715b049fcb800 (MD5) Previous issue date: 2010<br>Resumo: As hepatites virais constituem um importante problema de saúde pública. São doenças provocadas por agente etiológicos com tropismo primário pelo tecido hepático com características epidemiológicas, clínicas e laborato
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Brandão, Natália Alberto Alves. "Prevalência e fatores associados às infecções pelos vírus das hepatites B e C em pacientes HIV positivos, atendidos na rede pública de Goiânia - Goiás." Universidade Federal de Goiás, 2013. http://repositorio.bc.ufg.br/tede/handle/tede/3534.

Повний текст джерела
Анотація:
Submitted by Marlene Santos (marlene.bc.ufg@gmail.com) on 2014-11-04T19:15:44Z No. of bitstreams: 2 Dissertação - Natália Alberto Alves Brandão.pdf: 2752228 bytes, checksum: f1f4834b88d60df4f5620fe3e16ff30d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)<br>Approved for entry into archive by Jaqueline Silva (jtas29@gmail.com) on 2014-11-05T09:19:23Z (GMT) No. of bitstreams: 2 Dissertação - Natália Alberto Alves Brandão.pdf: 2752228 bytes, checksum: f1f4834b88d60df4f5620fe3e16ff30d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)<
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Erup, Louise, Alice Lettius, and Elisabeth Mollberg. "Sjuksköterskans bemötande till patienter med hepatit B och hepatit C : En litteraturstudie." Thesis, Högskolan i Halmstad, Akademin för hälsa och välfärd, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-41342.

Повний текст джерела
Анотація:
Bakgrund: Hepatit B och hepatit C räknas i dag som de största infektionssjukdomarna i världen med dödlig utgång. Sjukdomarna rapporteras som en världsomfattande börda och mellan år 2018 och 2019 uppgavs 1,9 miljoner människor avlidit. I omvårdnadsarbetet ska sjuksköterskan värna om patienten och arbeta personcentrerat, visa respekt och inte kränka patienten. Patienter med hepatit B och C har uttryckt sig känna av stigmatisering och förutfattade meningar om hur de smittats, de kände även av att bemötandet i omvårdnaden kunde påverkas negativt. Syftet med litteraturstudien var att utforska sjuks
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Bengsch, Bertram. "CD8+ T Zelldifferenzierung bei der Hepatitis B- und Hepatitis C-Virusinfektion." [S.l. : s.n.], 2007. http://nbn-resolving.de/urn:nbn:de:bsz:25-opus-60765.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Neto, Gaspar Lisboa. "Influência da infecção pregressa pelo vírus da hepatite B em portadores de hepatite C crônica: análise histológica." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5134/tde-02072009-095040/.

Повний текст джерела
Анотація:
INTRODUÇÃO: Os vírus das hepatites B (VHB) e C (VHC) são os principais causadores de hepatopatia crônica em todo mundo. Ambos compartilham vias semelhantes de transmissão. Em pacientes portadores crônicos de VHC com sorologia compatível com infecção pregressa pelo VHB (anti-HBcAg[+] e HBsAg [-]), o VHB DNA residual tem sido detectado por técnicas de biologia molecular altamente sensíveis no soro, em células linfomononucleares de sangue periférico e em hepatócitos (como cccDNA), de forma que o anti-HBcAg tem sido associado a pior prognóstico, tanto histológico quanto terapêutico. OBJETIVOS: Ana
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Laestadius, Hanna, and Berfin Güven. "Hur patienter med hepatit B och hepatit C upplever bemötandet av omvårdnadspersonal." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-397661.

Повний текст джерела
Анотація:
Background: In 2019, hepatitis is seen as one of the deadliest virus infections in the world and is seen as a global health problem. Hepatitis is a DNA-virus that can lead to chronic hepatitis and liver cirrhosis. Both hepatitis B and C are blood infections which means that they are transmitted through contact with damaged skin, mucus membrane or the eyes. Aim: The aim of this study was to describe how patients with hepatitis B and C experience the treatment from healthcare professionals. Method: The method used in this study was a review of literature research. The study was conducted through
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Hepatitis B and Hepatitis C"

1

Council, Pakistan Medical Research. Prevalence of hepatitis B & C in Pakistan. Pakistan Medical Research Council, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Shih, Chiaho. Chronic hepatitis B and C: Basic science to clinical applications. World Scientific, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Nakashima, Toshiaki. C-gata kan'en B-gata kan'en. Shufu No Tomosha, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Mattsson, Lars. Chronic non-A, non-B hepatitis: With special reference to the transfusion-associated form. Distributed by the Almqvist & Wiksell, 1989.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Sheila, Sherlock. Hepatitis C viral infection--an update. Blackwell Scientific Publications, 1989.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Reform, United States Congress House Committee on Oversight and Government. Viral hepatitis: The secret epidemic : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, second session, June 17, 2010. U.S. G.P.O., 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Dublin, Ireland. Minister for Justice, Equality, and Law Reform. and Trinity College (Dublin, Ireland). Dept. of Community Health and General Practice., eds. Hepatitis B, hepatitis C and HIV in Irish prisoners: Prevalence and risk. Stationery Office, 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

San Francisco (Calif). Dept. of Public Health. Communicable Disease Control Unit. Chronic hepatitis B and hepatitis C infection surveillance report: 2009, San Francisco, California. San Francisco Department of Public Health, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

San Francisco (Calif). Dept. of Public Health. Communicable Disease Control Unit. Chronic hepatitis B and hepatitis C infection surveillance report: 2010, San Francisco, California. San Francisco Department of Public Health, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

New York (State). Legislature. Assembly. Committee on Alcoholism and Drug Abuse. Public hearing on alcoholism and drug abuse and health: New York State's response to hepatitis A, B and C and methamphetamine. EN-DE Reporting, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Hepatitis B and Hepatitis C"

1

Carballo, Manuel, Rowan Cody, Megan Kelly, and Angelos Hatzakis. "Migration, Hepatitis B, and Hepatitis C." In Viral Hepatitis. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118637272.ch37.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Gane, Ed. "Liver Transplantation for Chronic Hepatitis B and C." In Viral Hepatitis. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118637272.ch15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Carithers, Robert L. "Epidemiology of Hepatitis B and Hepatitis C." In Chronic Viral Hepatitis. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-104-6_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

MacBrayne, Christine E., and Jennifer J. Kiser. "Hepatitis B and Hepatitis C Antiviral Agents." In Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72416-4_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Kim, W. Ray, and John J. Poterucha. "Hepatitis B and C." In Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444325249.ch19.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Carlin, Joseph, Maria Cassia Mendes-Correa, and Marina Núñez. "Hepatitis B and C." In Sexually Transmitted Infections in HIV-Infected Adults and Special Populations. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56694-8_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Edozien, Leroy C. "Hepatitis B and C." In The Labour Ward Handbook, 3rd ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781315099897-84.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Smith, Robert M., and George Y. Wu. "Molecular Virology of Hepatitis B and C." In Chronic Viral Hepatitis. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-104-6_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

"Hepatitis B, Hepatitis C, HIV." In Zahnärztliche Notfälle, edited by Gert J. Grubwieser, Michael A. Baubin, Heinrich J. Strobl, and Robert B. Zangerle. Georg Thieme Verlag, 2002. http://dx.doi.org/10.1055/b-0034-7174.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Yee, Leland J., and Mark R. Thursz. "Hepatitis B and Hepatitis C Infection." In Genetic Susceptibility to Infectious Diseases. Oxford University PressNew York, NY, 2008. http://dx.doi.org/10.1093/oso/9780195174908.003.0021.

Повний текст джерела
Анотація:
Abstract Infection with the hepatitis B or hepatitis C viruses may result in a number of different outcomes, ranging from asymptomatic self-limited (‘‘acute’’) infection to persistent (‘‘chronic’’) infection with liver cirrhosis, liver failure, or hepatocellular carcinoma. Therapeutic intervention in patients with persistent viral infection may lead to complete resolution of the infection and the associated liver disease, may fail, or may even exacerbate the liver disease. While it is clear that environmental and viral variables play an important role in determining some of these outcomes, it
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Hepatitis B and Hepatitis C"

1

Ekmen, Onder. "A Case of Fulminant Hepatitis B Reactivation After Hepatitis C Treatment in Hepatitis B+C Co-infection." In 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760078.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Lima, Laís Cruz, Maurício Prätzel Ellwanger, Manuela Pozza Ellwanger, et al. "CLINICAL AND EPIDEMIOLOGICAL PROFILE OF HEPATITIS B AND C PATIENTS IN A MUNICIPALITY IN SOUTHERN BRAZIL." In I Congresso Internacional Multidisciplinar de Ciências da Saúde - I CIMS. New Science Publishers, 2024. http://dx.doi.org/10.56238/i-cims-012.

Повний текст джерела
Анотація:
Context: Hepatitis B and C are common diseases with significant public health impacts. Hepatitis B is primarily transmitted through sexual contact, classifying it as a sexually transmitted infection, while hepatitis C is mainly transmitted through blood. Without early and proper treatment, these infections can lead to complications such as hepatocellular carcinoma and liver cirrhosis. Objective: To determine the clinical-epidemiological profile of hepatitis B and C patients treated at a specialized health center in a municipality in southern Santa Catarina from 2016 to 2020. Methods: A retrosp
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gür, A., M. Karakoç, MF Geyik, et al. "SAT0135 Association between hepatitis c virus antibody, hepatitis b virus antigen and fibromiyalgia." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.594.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

"PS-040 - RELEVANCIA DE LA PATOLOGÍA DUAL EN LA INFECCIÓN DEL VHC EN PACIENTES INGRESADOS EN LA UNIDAD DE HOSPITALIZACIÓN BREVE DE PSIQUIATRÍA DE SALAMANCA." In 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.ps040.

Повний текст джерела
Анотація:
La prevalencia de hepatitis C es claramente superior en pacientes con adicciones y se ha demostrado la relevancia de la presencia de patología dual en unidades de subagudos de Psiquiatría. Existen pocos datos de su prevalencia y relevancia en Unidades de Hospitalización Breve. Se estudia una muestra de 1841 ingresos realizados entre el enero del 2017 y octubre del 2021. Un 40% eran reingresos de pacientes por lo que se incluyen 1096 pacientes distintos (52,1% eran mujeres), edad media de edad 49,62 (DT=16,27). 340 sujetos (31,3%) padecían Trastornos psicóticos, 180 depresivos (17%), 105 Trasto
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Chien, J. H., D. S. Lee, W. P. Chou, et al. "Simultaneous Quantification for Hepatitis B Virus and Hepatitis C Virus Using Real-time PCR Lab-on-a-chip." In 2006 1st IEEE International Conference on Nano/Micro Engineered and Molecular Systems. IEEE, 2006. http://dx.doi.org/10.1109/nems.2006.334721.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Myazin, Roman Gennadievich. "THE RESULTS OF USING ALLOKIN-ALPHA AS ASTIMULATOR OF LEUCOPOESIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C." In Themed collection of papers from Foreign intemational scientific conference «Joint innovation - joint development». Medical sciences . Part 2. Ьу НNRI «National development» in cooperation with PS of UA. June 2023. Crossref, 2023. http://dx.doi.org/10.37539/230629.2023.42.38.020.

Повний текст джерела
Анотація:
The effects of Allokin-alfa were studied as a stimulator of leucopoesis in patients with chronic viral hepatitis B and C accompanied with interferon induced leucopenia. It is determined that when Allokin-alfa is used in complex therapy it decreases leucopenia and neutropenia and the number of leucocytes and segmented neutrophils (р &lt; 0,05) increases. Thus, it is proved Allokin-alfa has a positive effect on stimulation of leucopoesis and improves the results of analysis in leucopenia in patients with chronic viral hepatitis B and C.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Susilawati, Tri Nugraha, Alfin Titian Permata, and Sigit Setyawan. "The immunobiology of regulatory T cells in hepatitis B and C." In THE 2ND INTERNATIONAL CONFERENCE ON SCIENCE, MATHEMATICS, ENVIRONMENT, AND EDUCATION. AIP Publishing, 2019. http://dx.doi.org/10.1063/1.5139853.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Lin, Kwang-Huei, Yang-Hsiang Lin, and Yu-Chin Liu. "Abstract 1810: LncCGU1 and AFP serve as important prognostic marker in non-hepatitis B non-hepatitis C hepatocellular carcinoma." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-1810.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Lin, Kwang-Huei, Yang-Hsiang Lin, and Yu-Chin Liu. "Abstract 1810: LncCGU1 and AFP serve as important prognostic marker in non-hepatitis B non-hepatitis C hepatocellular carcinoma." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1810.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Mckee, Geoff, Nuria Chapinal, Zahid Butt, et al. "P388 Evolution of hepatitis C care cascades among HIV and hepatitis B co-infected patients in british columbia, canada." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.483.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Hepatitis B and Hepatitis C"

1

Tangkijvanith, Pisit. Prevalence and Clinical Significance of Hepatitis B Viral Genotypes and Mutations. Faculty of Medicine, Chulalongkorn University, 2006. https://doi.org/10.58837/chula.res.2006.24.

Повний текст джерела
Анотація:
Hepatitis B virus (HBV) infection is a major public health problem, with more than 400 million HBV carriers estimated worldwide. Chronic HBV infection is associated with a diverse clinical spectrum of liver damage ranging from asymptomatic carrier status, chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). There have been increasing lines of evidence to indicate influences of HBV genotypes and mutations on the outcome of liver disease, particularly the development of HCC. The project is aimed to study the prevalence and clinical significance of genotypes and mutations in Precore/
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Nguyen, Tung, Mandana Khalili, Janice Tsoh, et al. Comparing Ways to Increase Hepatitis B and C Screening Among Asian Americans. Patient-Centered Outcomes Research Institute® (PCORI), 2020. http://dx.doi.org/10.25302/02.2020.ad.12114615.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Goller, Jane, Stephanie Munari, Cassandra Caddy, et al. General Practice engagement: STI, HIV and viral hepatitis care. The Sax Institute, 2023. http://dx.doi.org/10.57022/lnur4773.

Повний текст джерела
Анотація:
Early detection and treatment of sexually transmitted infections, HIV, and hepatitis B and C are vital to minimise the harm they cause. This Evidence Check aimed to identify effective initiatives that engage and support GPs and the GP clinic workforce in NSW to increase testing for these conditions. It also aimed to identify effective modifications to practice management software to increase GP engagement in screening and care for these conditions. Sixty-two articles were found in total. The most effective initiatives used multiple interventions, particularly provider education and quality imp
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Kancheva, Lyudmila, Petar Nikolov, Tsvetelina Velikova, Ivan Valkov, Rossen Nikolov, and Lyudmila Mateva. Soluble CD14 is Associated with Disease Activity and Severity in Chronic Viral Hepatitis C and B. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2018. http://dx.doi.org/10.7546/crabs.2018.06.17.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Saraswati, Lopamudra, Mary Sebastian, Avina Sarna, et al. Prevalence of HIV, hepatitis B and C, and co-infection in a cohort of male injection drug users in Delhi. Population Council, 2013. http://dx.doi.org/10.31899/hiv10.1001.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Xu, Yan, Yuyang Zhao, Yong Wang, et al. Concurrent hepatic steatosis increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B or C virus infection: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.7.0099.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kuypers, Marshall A., Gregory Joseph Lambert, Thomas W. Moore, et al. Modeling Hepatitis C treatment policy. Office of Scientific and Technical Information (OSTI), 2013. http://dx.doi.org/10.2172/1096266.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sjogren, Maria H., and Kent Holtzmuller. Hepatitis C Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada406083.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Sjogren, Maria H. Hepatitis C. Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada433067.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Sjogren, Maria H., and Brooke Huntley. Hepatitis C. Virus Infection: Mechanisms of Disease Progression. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada477987.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Hepatitis B and Hepatitis C" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії